Credit: John Sennett. It is necessary to develop additional COVID-19 vaccines, as different vaccine approaches have their advantages and disadvantages and may work synergistically. Researchers at...
Shares of Vaxart cratered 58% after early preliminary trial data showed that its oral COVID-19 vaccine did not produce neutralizing antibodies
A scientific detective story unearths how SARS-CoV-2 evolves new variants that evade antibodies Credit: Kevin McCarthy and Paul Duprex PITTSBURGH, Feb. 3, 2020 – In a...
GlaxoSmithKline is partnering with Germany’s CureVac to manufacture 100 million doses of that company’s mRNA Covid-19 vaccine CVnCoV, and collaborating to develop a next-generation multi-valent Covid-19 vaccine aimed...
The E484K mutation has been found in the UK variant. Here's what it means.
Credit: UIC The SARS-CoV-2, the new coronavirus behind the current pandemic, infects humans by binding its surface-exposed spike proteins to ACE2 receptors exposed on the cell...
Stirred to action by the COVID-19 pandemic, vaccine stalwarts mobilize new formats, accelerate development, and scale up manufacturing. The post The Sleeping Giants of Vaccine Production...
Immuneering uses bioinformatically tuned target identification and hit finding platforms to generate drug candidates that can tamp down aberrant signalling. The post Disease Cancelling Technology Emulates...
Where conventional mass spec struggles with sequencing and the recognition of isoforms and post-translational modifications, new technologies may shine. The post Proteomics Begins to Emerge from...
UK Finds "Mutations Of Concern" In Bristol And Liverpool: Health Secretary Authored by Alexander Zhang via The Epoch Times, British health authorities have identified 43 cases...
Technology based on nanoparticles identifies IgG antibodies and costs only about a fifth of similar devices now on the market. It was developed by scientists at...
After months of touting its efficacy to the western world, the efficacy of Russia’s Sputnik V vaccine was validated in a peer-reviewed study published in The...
A roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for Covid-19 includes research on long-lasting...
The virus is evolving and new strains are more transmissible. Will the vaccines work against these new variants? How can researchers stay ahead of the virus's...
Diversifying a portfolio is often cited as a safe investing strategy, but it is also the game plan adopted by Sorrento Therapeutics (SRNE). This varied approach...
Credit: The Grainger College of Engineering As the numbers of those infected with COVID-19 has continued to climb, the desperate need for a vaccine was apparent....
Tensions run high as EU vaccine deliveries fall behind schedule, while new vaccines are being created to handle mutant viral strains.
The EMA has approved AstraZeneca’s COVID-19 vaccine for use in the EU in all adults aged over 18
The vaccine is still very likely to be protective in over-65s, even if efficacy in this age group is unknown.
The method analyzes saliva samples and delivers results in about 10 minutes Credit: UArizona Biosensors Lab Researchers at the University of Arizona are developing a COVID-19...
On the face of it, it seems like a good idea.
Theories that antibodies affect the placenta are completely unfounded.
When mixed with fluid from a nasal swab or blood sample, these protein sensors emit light within minutes. Credit: Ian Haydon/UW Medicine Institute for Protein Design...
The data continues to come in on the various Covid-19 variants, and so far the news is pretty good, according to BioSpace.
Engineers and oncologists teamed to develop a microfluidic chip capable of capturing the body’s natural killer immune cells to harvest their cancer-killing exosomes Credit: Image courtesy...
All Hail The Reopening! Authored by Jeffrey Tucker via The American Institute for Economic Research, What a glorious thing the reopening is! After nearly a year...
With slow vaccine distribution and manufacturing, some people won't get the second dose on time. But does it matter?
Pfizer Inc. and BioNTech’s Covid-19 vaccine appeared to lose only a small bit of effectiveness against a new coronavirus variant found in South Africa
The UK government has claimed the new British variant of the coronavirus may be 30% more deadly.
Financial markets experienced a minor taper tantrum overnight, although my mother, having endured years of bringing up a highly-strung devil child, would even rate it as...